Use of (3-(2-ethylphenyl)-5-methoxyphenyl)-1H-[1,2,4]-triazole for the treatment of autoimmune diseases

   
   

The present invention discloses a method for treating a subject affected by an autoimmune disease, in particular multiple sclerosis, lupus erythematosus systemicus and rheumatoid arthritis, comprising administering to said subject an effective amount of 3-(2-ethylphenyl)-5-methoxy-1H-1,2,4-tirazole. The present invention further discloses a method for inhibiting .gamma..delta. T cells in a subject in need thereof, said method comprising administering to said subject an effective amount of the same compound.

La presente invenzione rileva un metodo per trattare un oggetto influenzato da una malattia autoimmune, in particolare sclerosi a placche, systemicus di erythematosus di lupus ed artrite rheumatoid, contenenti amministrando all'oggetto detto un la quantità efficace di 3-(2-ethylphenyl)-5-methoxy-1H-1,2,4-tirazole. La presente invenzione ulteriore rileva un metodo per l'inibizione del gamma..delta. Cellule di T in un oggetto nel bisogno di ciò, metodo detto che contiene amministrando all'oggetto detto un la quantità efficace dello stesso residuo.

 
Web www.patentalert.com

< Sigma ligands for neuronal regeneration and functional recovery

< Preventives and remedies for diseases in association with demyelination

> Substituted heterocyclic compounds and methods of use

> Therapeutic agents for multiple sclerosis

~ 00173